US — Revenue
Zimmer Biomet Holdings US — Revenue decreased by 7.9% to $1.21B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.6%, from $1.11B to $1.21B. Over 4 years (FY 2021 to FY 2025), US — Revenue shows an upward trend with a 5.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests successful market penetration, effective pricing strategies, or higher surgical procedure volumes in the US, while a decrease may indicate competitive pressure or market saturation.
Detailed definition
This metric represents the total gross revenue generated from the sale of orthopedic products and surgical services with...
Peer comparison
Comparable to regional net sales or geographic revenue reported by other global medical device manufacturers.
zbh_segment_us_revenue_from_contract_with_customer_excluding_assessed_taxHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.00B | $942.60M | $1.02B | $941.20M | $1.02B | $973.00M | $1.08B | $1.06B | $1.07B | $1.03B | $1.13B | $1.10B | $1.11B | $1.05B | $1.18B | $1.11B | $1.17B | $1.16B | $1.31B | $1.21B |
| QoQ Change | — | -6.1% | +8.0% | -7.5% | +8.1% | -4.4% | +11.1% | -1.9% | +0.8% | -3.5% | +9.4% | -2.6% | +0.6% | -4.9% | +12.3% | -5.7% | +5.4% | -0.8% | +12.8% | -7.9% |
| YoY Change | — | — | — | — | +1.3% | +3.2% | +6.1% | +12.7% | +5.0% | +6.0% | +4.4% | +3.7% | +3.5% | +2.0% | +4.7% | +1.3% | +6.1% | +10.6% | +11.1% | +8.6% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Zimmer Biomet Holdings's us — revenue?
- Zimmer Biomet Holdings (ZBH) reported us — revenue of $1.21B in Q1 2026.
- How has Zimmer Biomet Holdings's us — revenue changed year-over-year?
- Zimmer Biomet Holdings's us — revenue increased by 8.6% year-over-year, from $1.11B to $1.21B.
- What is the long-term trend for Zimmer Biomet Holdings's us — revenue?
- Over 4 years (2021 to 2025), Zimmer Biomet Holdings's us — revenue has grown at a 5.4% compound annual growth rate (CAGR), from $3.85B to $4.76B.
- What does us — revenue mean?
- The total sales revenue generated from customers in the United States, excluding tax collections.